SCHEMBL29548320

SCHEMBL29548320

O=c1c2ccc(Cl)nc2oc2c(F)cccc12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ PRKDC P78527 1/20 0.36
▸ CYP1B1 Q16678 1/20 0.36
▸ ATP1A1 P05023 1/20 0.36
▸ ATP1B1 P05026 1/20 0.36
▸ ATP1A3 P13637 1/20 0.36
▸ ATP1B2 P14415 1/20 0.36
▸ ATP1A2 P50993 1/20 0.36
▸ ATP1B3 P54709 1/20 0.36
▸ FXYD2 P54710 1/20 0.36
▸ ATP1A4 Q13733 1/20 0.36
▸ TTR P02766 3/20 0.35
▸ GABRP O00591 2/20 0.35
▸ GABRD O14764 2/20 0.35
▸ GABRA1 P14867 2/20 0.35
▸ GABRB1 P18505 2/20 0.35
▸ GABRG2 P18507 2/20 0.35
▸ GABRB3 P28472 2/20 0.35
▸ GABRA5 P31644 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19642363 1.00 CYP1A1 (0.36) CYP1A1CYP1A2PRKDCCYP1B1ATP1A1
SCHEMBL19642396 0.84 ATP1A1 (0.41) CYP1A1CYP1A2PRKDCCYP1B1ATP1A1
SCHEMBL2516020 0.78 KDM4E (0.57) CYP1A2CYP1B1ATP1A1ATP1B1ATP1A3
SCHEMBL8815403 0.78 ATP1A1 (0.47) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL19642440 0.77 MAOB (0.46) PRKDCKDM4EELANE
SCHEMBL29547657 0.77 MAOB (0.46) PRKDCKDM4EELANE
SCHEMBL22171892 0.74 KDM4E (0.60) TTRMAOAKDM4EALDH1A1MEN1
SCHEMBL19642411 0.74 CA12 (0.32) ATP1A1ATP1B1ATP1A3ATP1B2ATP1A2
SCHEMBL5782106 0.70 MAOA (0.64) MAOAKDM4EALDH1A1CYP3A4
SCHEMBL29547534 0.70 MAOA (0.64) MAOAKDM4EALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109311860-B Xanthone derivatives for the treatment or prevention of hepatitis B virus diseases 豪夫迈·罗氏有限公司 2022-04-08 — — CN disclosed
Send feedback